Neuravi

Indonesia
Tangkanpulit, West Nusa Tenggara, Indonesia

Company profile

Neuravi company profile

Neuravi is an early stage company in the large emerging neurointerventional device market. Led by a team experienced in endovascular device development and global commercialization, the company's initial technology platform addresses acute ischemic stroke. In collaboration with international researchers and clinicians, the company seeks to develop new understanding that will drive innovative solutions to treat this challenging and devastating disease. Neuravi was founded in 2009 and is headquartered in Galway, Ireland, home to many of the world’s leading medical device companies.

Business identity

Contact email
[email protected]
Phone number
+353 9 139 4114
Operating status
Closed
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2009-01-01, Year

Headquarters

Country code
ID
Continent
Asia

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
3
Total equity funding
$27.9M
Last funding
Debt Financing / $16.6M / 2016-11-02
Last equity funding
Series B / $21.5M
Investors
5
Lead investors
3
Founders
3
Articles
5
Exited on
2017-04-10

Founders and investors

Founders

David ValeEamon BradyJohn O’Shaughnessy

Lead investors

EQT Life SciencesFountain Healthcare PartnersIPF Partners

Investors

Delta PartnersEQT Life SciencesFountain Healthcare PartnersIPF PartnersWestern Development Commission